No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Distribution
McKesson Corporation functions as a prominent global provider of healthcare services, serving markets within the United States and across various international regions. Its extensive operations are organized into four principal operating segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical division is responsible for the widespread distribution of a diverse range of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, as well as various other healthcare commodities. This segment additionally furnishes critical support, encompassing practice management, technological aid, clinical guidance, and diverse business solutions tailored for community-based oncology and other specialized medical practices. Furthermore, it offers pharmacies consulting, outsourcing, and technology services, alongside integrated financial, operational, and clinical solutions. The International segment extends its distribution network and comprehensive services to wholesale, institutional, and retail customers throughout 13 European nations and Canada. The Medical-Surgical Solutions division is devoted to providing healthcare providers with medical and surgical supply distribution, intricate logistics management, and supplementary services. The Prescription Technology Solutions (RxTS) segment is dedicated to resolving medication-related hurdles for patients across their entire treatment trajectory, working in partnership with biopharma and life sciences organizations. It also serves as a crucial link, connecting pharmacies, healthcare providers, payers, and biopharma companies to deploy cutting-edge solutions for enhancing medication access and adherence. Moreover, RxTS supplies robust third-party logistics and wholesale distribution assistance. Established in 1833, McKesson Corporation's corporate headquarters are situated in Irving, Texas.
www.mckesson.comNo one on the platform currently holds 0JZU.L.
No tracked institution reports a position in 0JZU.L as of their last filing.
No one on the platform has traded 0JZU.L yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 212.4% | — | — | — | ||
| Rev. Growth % | 12.4% | 11.1% | ||||
| Profit Margin % | 1.2% | 1.0% | 0.6% | |||
| Free Cash Flow Margin % | 1.4% | 1.4% | 1.6% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $432.0B | +5.8% | $44.63 | $43.39–$45.59 | — | 1 |
| 2028 | $462.2B | +7.0% | $50.55 | $49.15–$51.64 | — | 1 |
| 2029 | $496.6B | +7.4% | $57.77 | $56.17–$59.02 | — | 1 |
| 2030 | $515.5B | +3.8% | $67.67 | $65.79–$69.13 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 8 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-05 | $9.56 | $9.93 | +3.9% |
| 2026-05-07 | $11.56 | $11.69 | +1.1% |
| 2026-02-04 | $9.17 | $9.34 | +1.9% |
| 2025-11-05 | $9.03 | $9.86 | +9.2% |
| 2025-08-06 | $8.14 | $8.26 | +1.5% |
| 2025-05-08 | $9.83 | $10.12 | +3.0% |
| 2025-02-05 | $7.99 | $8.03 | +0.5% |
| 2024-11-06 | $6.88 |
| $7.07 |
| +2.8% |
| -0.97% |
| $120.3B |
| — |
| 0J1R.LHCA Healthcare, Inc. | $423.59 | +0.64% | $95.7B | — |
| 0J8P.LIDEXX Laboratories, Inc. | $511.31 | +0.67% | $40.3B | — |
Source: Financial Modeling Prep · peers by sector/industry